ARCHIVES

Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says

This article is from The Cancer Letter archive.

Vol. 16 No. 16 | April 20, 1990

Download PDF Visit The Full Archive

Related Articles

Leptin Could Be Indicator Of Breast Cancer Risk

April 25, 2003

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

Prominent Duke Scientist Claimed Prizes He Didn’t Win, Including Rhodes Scholarship

July 16, 2010

In Brief: Steve Carter Accepts Job With Bristol, Phillips Elected NCG Chairman; Murray Copeland Dies

April 9, 1982

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999